People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Spotlight reports on this and some of the ...

For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

The Sunday Mail Dr Mombeshora Emmanuel Kafe In a move to ensure critical healthcare services continue uninterrupted, the ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...